S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
NYSEAMERICAN:SYN

Synthetic Biologics News Headlines

$0.91
+0.07 (+7.72 %)
(As of 01/22/2021 05:29 PM ET)
Add
Compare
Today's Range
$0.85
Now: $0.91
$0.95
50-Day Range
$0.32
MA: $0.37
$0.50
52-Week Range
$0.25
Now: $0.91
$1.70
Volume22.64 million shs
Average Volume46.05 million shs
Market Capitalization$18.23 million
P/E RatioN/A
Dividend YieldN/A
Beta2.29

Headlines

Synthetic Biologics (NYSEAMERICAN SYN) News Headlines Today

Source:
SourceHeadline
Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) Short Interest UpdateSynthetic Biologics, Inc. (NYSEAMERICAN:SYN) Short Interest Update
americanbankingnews.com - January 17 at 10:58 PM
Synthetic Biologics (NYSEAMERICAN:SYN) Trading Down 12%Synthetic Biologics (NYSEAMERICAN:SYN) Trading Down 12%
americanbankingnews.com - January 13 at 11:18 PM
Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Up to $0.65Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Up to $0.65
americanbankingnews.com - January 12 at 12:53 PM
Synthetic Biologics (NYSEAMERICAN:SYN) Trading Up 8.2%Synthetic Biologics (NYSEAMERICAN:SYN) Trading Up 8.2%
americanbankingnews.com - January 11 at 8:14 PM
Synthetic Biologics (NYSEAMERICAN:SYN)  Shares Down 21.4% Synthetic Biologics (NYSEAMERICAN:SYN) Shares Down 21.4%
americanbankingnews.com - January 7 at 9:35 PM
Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Down to $1.00Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Down to $1.00
americanbankingnews.com - January 6 at 1:40 PM
Synthetic Biologics (NASDAQ:SYN) Shares Gap Up to $0.50Synthetic Biologics (NASDAQ:SYN) Shares Gap Up to $0.50
americanbankingnews.com - January 5 at 10:40 AM
Synthetic Biologics (NYSE:SYN) Shares Gap Up to $0.50Synthetic Biologics (NYSE:SYN) Shares Gap Up to $0.50
americanbankingnews.com - January 5 at 10:40 AM
Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Up to $0.50Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Up to $0.50
americanbankingnews.com - January 5 at 10:40 AM
Synthetic Biologics (NYSEAMERICAN:SYN) Trading Up 12.6%Synthetic Biologics (NYSEAMERICAN:SYN) Trading Up 12.6%
americanbankingnews.com - December 30 at 6:58 PM
Synthetic Biologics (NYSEAMERICAN:SYN)  Shares Down 3.5% Synthetic Biologics (NYSEAMERICAN:SYN) Shares Down 3.5%
americanbankingnews.com - December 28 at 9:28 PM
Synthetic Biologics Announces Extension of Compliance Plan Period by NYSE AmericanSynthetic Biologics Announces Extension of Compliance Plan Period by NYSE American
finance.yahoo.com - November 24 at 8:01 AM
Synthetic Biologics Engages A.G.P./Alliance Global Partners as Advisor to Assist in Evaluating Strategic OptionsSynthetic Biologics Engages A.G.P./Alliance Global Partners as Advisor to Assist in Evaluating Strategic Options
finance.yahoo.com - November 16 at 8:38 AM
MustGrow Biologics Corp to Present at the virtual Fall Investor Summit on November 16th-18thMustGrow Biologics Corp to Present at the virtual Fall Investor Summit on November 16th-18th
finanznachrichten.de - November 12 at 7:18 PM
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of DirectorsSynthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
finance.yahoo.com - November 12 at 9:16 AM
Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2020 Results - Earnings Call TranscriptSynthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 7:40 PM
Synthetic Biologics, Inc. to Host Earnings CallSynthetic Biologics, Inc. to Host Earnings Call
finance.yahoo.com - November 10 at 5:29 PM
Synthetic Biologics Reports 2020 Third Quarter Operational Highlights and Financial ResultsSynthetic Biologics Reports 2020 Third Quarter Operational Highlights and Financial Results
finance.yahoo.com - November 10 at 5:29 PM
Synthetic Biologics Inc.Synthetic Biologics Inc.
barrons.com - November 7 at 2:33 PM
Synthetic Biologics to Report 2020 Third Quarter Operational Highlights and Financial Results on November 10, 2020Synthetic Biologics to Report 2020 Third Quarter Operational Highlights and Financial Results on November 10, 2020
finance.yahoo.com - November 3 at 6:32 PM
Synthetic Biologics, Inc. Common Stock (SYN)Synthetic Biologics, Inc. Common Stock (SYN)
nasdaq.com - October 18 at 7:26 PM
Maxim Group Downgrades Synthetic Biologics to HoldMaxim Group Downgrades Synthetic Biologics to Hold
benzinga.com - October 6 at 7:21 AM
Synthetic Bios lead candidate flunks irritable bowel study; shares down 42%Synthetic Bio's lead candidate flunks irritable bowel study; shares down 42%
seekingalpha.com - October 4 at 12:38 AM
At CAGR Of 19.8%, Human Microbiome Market Growth, Opportunities, Industry Applications, Analysis And Forecast To 2025At CAGR Of 19.8%, Human Microbiome Market Growth, Opportunities, Industry Applications, Analysis And Forecast To 2025
marketwatch.com - September 25 at 5:23 PM
Global IBS Treatment Market 2020 Applications, Market Size According to a Specific Product, Sales and Revenue by Region 2025Global IBS Treatment Market 2020 Applications, Market Size According to a Specific Product, Sales and Revenue by Region 2025
marketwatch.com - September 22 at 5:03 AM
Biorez™ Raises $3.5 Million to Close Out $7 Million in Seed FinancingBiorez™ Raises $3.5 Million to Close Out $7 Million in Seed Financing
finance.yahoo.com - September 9 at 12:46 PM
Synthetic identity theft: Beware! Credit card users must know about this online fraudSynthetic identity theft: Beware! Credit card users must know about this online fraud
msn.com - September 9 at 12:46 PM
Ophthalmic Sutures Market: Overview, Opportunities, In-Depth Analysis and Forecasts, Outlook 2025Ophthalmic Sutures Market: Overview, Opportunities, In-Depth Analysis and Forecasts, Outlook 2025
marketwatch.com - September 9 at 12:46 PM
Asia Pacific Bone Grafts & Substitutes Market Size, Share & Trends Analysis Report By Product, By Application And Segment Forecasts, 2020 - 2027Asia Pacific Bone Grafts & Substitutes Market Size, Share & Trends Analysis Report By Product, By Application And Segment Forecasts, 2020 - 2027
finance.yahoo.com - September 9 at 12:46 PM
Global Synthetic Butadiene Market 2020 Top Industry Players, Regional Study, Growth Drivers, Challenges and Opportunities by 2025Global Synthetic Butadiene Market 2020 Top Industry Players, Regional Study, Growth Drivers, Challenges and Opportunities by 2025
marketwatch.com - September 9 at 3:35 AM
Synthetic Biology Platforms Market to Witness Excellent Growth | Intrexon, Amyris, GenScripSynthetic Biology Platforms Market to Witness Excellent Growth | Intrexon, Amyris, GenScrip
marketwatch.com - September 7 at 6:20 PM
Global Synthetic Monitoring Tools Market 2020 Report Explores Key Regions, Company Profile, Opportunity and Challenge to 2025Global Synthetic Monitoring Tools Market 2020 Report Explores Key Regions, Company Profile, Opportunity and Challenge to 2025
marketwatch.com - September 7 at 12:20 AM
Spine Biologics Market to Reach USD 2,629.6 Million By 2027 | CAGR: 3.9% | Reports And DataSpine Biologics Market to Reach USD 2,629.6 Million By 2027 | CAGR: 3.9% | Reports And Data
finanznachrichten.de - September 4 at 5:26 PM
Synthetic Biologics (SYN) CEO Steven Shallcross on Q2 2020 Results - Earnings Call TranscriptSynthetic Biologics' (SYN) CEO Steven Shallcross on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 11:06 PM
58 Stocks Moving In Thursdays Regular-Market Session58 Stocks Moving In Thursday's Regular-Market Session
www.benzinga.com - August 1 at 8:08 PM
Synthetic Biologics on go with first study of enzyme therapy for gut healthSynthetic Biologics on go with first study of enzyme therapy for gut health
seekingalpha.com - July 30 at 11:19 AM
Protein A-Resins Market Witnessing Investment Exodus From Biopharmaceutical Manufacturers: Future Market Insights ReportProtein A-Resins Market Witnessing Investment Exodus From Biopharmaceutical Manufacturers: Future Market Insights Report
www.prnewswire.com - July 13 at 12:27 PM
IBS Treatment Market Share 2020 – Global Growth, Trends, Industry Analysis, Key Players and Forecast 2020 – 2023IBS Treatment Market Share 2020 – Global Growth, Trends, Industry Analysis, Key Players and Forecast 2020 – 2023
www.marketwatch.com - July 9 at 8:15 AM
BRIEF-Synthetic Biologics Announces Submission Of Ind Application To U.S. FDA For Syn-020 Intestinal Alkaline PhosphataseBRIEF-Synthetic Biologics Announces Submission Of Ind Application To U.S. FDA For Syn-020 Intestinal Alkaline Phosphatase
www.reuters.com - June 30 at 9:01 AM
Synthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline PhosphataseSynthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline Phosphatase
finance.yahoo.com - June 30 at 9:01 AM
Synthetic Bio inks deal to advance development of candidate SYN-020Synthetic Bio inks deal to advance development of candidate SYN-020
seekingalpha.com - May 27 at 9:52 AM
BRIEF-Synthetic Biologics Enters Option To License Intellectual Property For Use Of SYN-020 For Age-Related Metabolic, Inflammatory DiseasesBRIEF-Synthetic Biologics Enters Option To License Intellectual Property For Use Of SYN-020 For Age-Related Metabolic, Inflammatory Diseases
www.reuters.com - May 27 at 9:52 AM
Synthetic Biologics Enters into Exclusive Option to License Intellectual Property for Use of SYN-020 to Treat and Prevent Age-Related Metabolic and Inflammatory DiseasesSynthetic Biologics Enters into Exclusive Option to License Intellectual Property for Use of SYN-020 to Treat and Prevent Age-Related Metabolic and Inflammatory Diseases
finance.yahoo.com - May 27 at 7:04 AM
Edited Transcript of SYN earnings conference call or presentation 5-May-20 8:30pm GMTEdited Transcript of SYN earnings conference call or presentation 5-May-20 8:30pm GMT
finance.yahoo.com - May 14 at 11:58 PM
Sýn hf.: Q1 2020 affected by the COVID-19 pandemicSýn hf.: Q1 2020 affected by the COVID-19 pandemic
finance.yahoo.com - May 13 at 12:42 PM
How Synthetic Biologics, Inc. (NYSEMKT:SYN) Can Impact Your Portfolio VolatilityHow Synthetic Biologics, Inc. (NYSEMKT:SYN) Can Impact Your Portfolio Volatility
finance.yahoo.com - May 6 at 11:12 AM
BRIEF-Synthetic Biologics Reports Qtrly Loss Per Share $0.20BRIEF-Synthetic Biologics Reports Qtrly Loss Per Share $0.20
www.reuters.com - May 5 at 11:53 PM
Synthetic Biologics (SYN) CEO Steven Shallcross on Q1 2020 Results - Earnings Call TranscriptSynthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 11:53 PM
Synthetic Biologics EPS beats by $0.07Synthetic Biologics EPS beats by $0.07
seekingalpha.com - May 5 at 5:11 PM
Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial ResultsSynthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results
finance.yahoo.com - May 5 at 5:11 PM
This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.